• In the past year, Allstate insiders were net sellers of shares, with Chairman Thomas Wilson disposing of about US$38,000,000, or 13% of his holdings, while insiders still retain roughly US$278,000,000 in stock.
• Analysts currently expect stronger quarterly earnings and growth in key insurance metrics like net premiums earned and protection services revenues, even after slightly trimming earnings per share estimates.
• With analysts expecting stronger earnings and core insurance growth, we'll now examine how this updated outlook reshapes Allstate's existing investment narrative.

AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Allstate Investment Narrative Recap

To own Allstate, you need to believe it can keep growing its core insurance franchise while managing structural pressures in auto, competition, and climate risk. The key short term catalyst is whether upcoming results confirm analysts’ expectations for stronger earnings and growth in net premiums and protection services. Recent insider selling, including Chairman Thomas Wilson’s US$38,000,000 sale, does not appear to materially alter that near term earnings focus, though it may sharpen attention on execution risks.

Against this backdrop, Allstate’s ongoing share repurchase program stands out. The company bought back over US$1,239,760,000 of stock in 2025, while also increasing its quarterly dividend to US$1.08 in early 2026. These capital returns sit alongside expectations for core insurance growth and help frame the debate around how much earnings power is already reflected in the share price, especially if underwriting volatility or regulatory constraints on pricing were to intensify.

But while recent results and analyst forecasts look constructive, investors should be aware that climate driven catastrophe volatility and tighter rate oversight could...

Allstate's narrative projects $76.3 billion revenue and $4.3 billion earnings by 2028. This requires 4.9% yearly revenue growth and a $1.4 billion earnings decrease from $5.7 billion today.

Uncover how Allstate's forecasts yield a $236.05 fair value, a 10% upside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts paint a much harsher picture, assuming earnings could fall toward about US$4.9 billion by 2029 and margins compress, highlighting how differently you and others might view Allstate’s capital returns and auto exposure once this latest insider selling and earnings news is fully reflected in fresh forecasts.

Explore 6 other fair value estimates on Allstate - why the stock might be worth 11% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Allstate research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Allstate research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Allstate's overall financial health at a glance.

Searching For A Fresh Perspective?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.